Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Malik Kahook to Ophthalmic Solutions

This is a "connection" page, showing publications Malik Kahook has written about Ophthalmic Solutions.

 
Connection Strength
 
 
 
3.012
 
  1. Kahook MY, Rapuano CJ, Messmer EM, Radcliffe NM, Galor A, Baudouin C. Preservatives and ocular surface disease: A review. Ocul Surf. 2024 10; 34:213-224.
    View in: PubMed
    Score: 0.825
  2. Seibold LK, Wagner BD, Lynch AM, Kahook MY. The Diurnal and Nocturnal Effects of Pilocarpine on Intraocular Pressure in Patients Receiving Prostaglandin Analog Monotherapy. J Ocul Pharmacol Ther. 2018 10; 34(8):590-595.
    View in: PubMed
    Score: 0.548
  3. Rolando M, Crider JY, Kahook MY. Ophthalmic preservatives: focus on polyquaternium-1. Expert Opin Drug Deliv. 2011 Nov; 8(11):1425-38.
    View in: PubMed
    Score: 0.337
  4. Kahook MY, Noecker R. Quantitative analysis of conjunctival goblet cells after chronic application of topical drops. Adv Ther. 2008 Aug; 25(8):743-51.
    View in: PubMed
    Score: 0.272
  5. Kahook MY, Serle JB, Mah FS, Kim T, Raizman MB, Heah T, Ramirez-Davis N, Kopczynski CC, Usner DW, Novack GD. Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2). Am J Ophthalmol. 2019 04; 200:130-137.
    View in: PubMed
    Score: 0.140
  6. Ianchulev T, Chayet A, Kahook M, Packer M, Pasquale L, Weinreb RN. Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper. Ther Deliv. 2016 11; 7(11):751-760.
    View in: PubMed
    Score: 0.120
  7. SooHoo JR, Golas L, Marando CM, Seibold LK, Pantcheva MB, Ramulu PY, Kahook MY. Glaucoma Patient Treatment Preferences. Ophthalmology. 2016 07; 123(7):1621-2.
    View in: PubMed
    Score: 0.115
  8. Marando CM, Seibold LK, SooHoo JR, Pantcheva MB, Ramulu PY, Kahook MY. The Utility of Cap Color and Bottle Characteristics for Topical Glaucoma Therapy. Ophthalmology. 2015 Dec; 122(12):2577-8.
    View in: PubMed
    Score: 0.109
  9. Seibold LK, Kahook MY. The diurnal and nocturnal effect of travoprost with sofZia on intraocular pressure and ocular perfusion pressure. Am J Ophthalmol. 2014 Jan; 157(1):44-49.e1.
    View in: PubMed
    Score: 0.098
  10. Seibold LK, Ammar DA, Kahook MY. Acute effects of glaucoma medications and benzalkonium chloride on pre-adipocyte proliferation and adipocyte cytotoxicity in vitro. Curr Eye Res. 2013 Jan; 38(1):70-4.
    View in: PubMed
    Score: 0.091
  11. Ammar DA, Noecker RJ, Kahook MY. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells. Adv Ther. 2010 Nov; 27(11):837-45.
    View in: PubMed
    Score: 0.079
  12. Ammar DA, Kahook MY. The effects of combination glaucoma medications on ocular surface epithelial cells. Adv Ther. 2009 Oct; 26(10):970-5.
    View in: PubMed
    Score: 0.074
  13. Kahook MY, Noecker RJ. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears. Cornea. 2008 Apr; 27(3):339-43.
    View in: PubMed
    Score: 0.066
  14. Torres JA, Fischer NA, Seibold LK, Pantcheva MB, Kahook MY, SooHoo JR. A Survey of Patient Perceptions and Preferences for Glaucoma Treatment with Intravitreal Injections. Ophthalmol Glaucoma. 2018 Jul - Aug; 1(1):61-65.
    View in: PubMed
    Score: 0.034
  15. Varadaraj V, Kahook MY, Ramulu PY, Pitha IF. Patient Acceptance of Sustained Glaucoma Treatment Strategies. J Glaucoma. 2018 04; 27(4):328-335.
    View in: PubMed
    Score: 0.033
  16. Dave P, Villarreal G, Friedman DS, Kahook MY, Ramulu PY. Ability of Bottle Cap Color to Facilitate Accurate Patient-Physician Communication Regarding Medication Identity in Patients with Glaucoma. Ophthalmology. 2015 Dec; 122(12):2373-9.
    View in: PubMed
    Score: 0.028
  17. Barker GT, Cook PF, Schmiege SJ, Kahook MY, Kammer JA, Mansberger SL. Psychometric properties of the Glaucoma Treatment Compliance Assessment Tool in a multicenter trial. Am J Ophthalmol. 2015 Jun; 159(6):1092-1099.e2.
    View in: PubMed
    Score: 0.027
  18. Cronin TH, Kahook MY, Lathrop KL, Noecker RJ. Accuracy and performance of a commercially available Dosing Aid. Br J Ophthalmol. 2007 Apr; 91(4):497-9.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)